| Literature DB >> 26291924 |
Duc J Vugia, James I Meek, Richard N Danila, Timothy F Jones, William Schaffner, Joan Baumbach, Sarah Lathrop, Monica M Farley, Melissa Tobin-D'Angelo, Lisa Miller, Lee H Harrison, Nancy M Bennett, Paul R Cieslak, Matthew L Cartter, Arthur L Reingold.
Abstract
One objective of the Emerging Infections Program (EIP) of the US Centers for Disease Control and Prevention is to provide training opportunities in infectious disease epidemiology. To determine the extent of training performed since the program's inception in 1995, we reviewed training efforts at the 10 EIP sites. By 2015, all sites hosted trainees (most were graduate public health students and physicians) who worked on a variety of infectious disease surveillance and epidemiologic projects. Trainee projects at all sites were used for graduate student theses or practicums. Numerous projects resulted in conference presentations and publications in peer-reviewed journals. Local public health and health care partners have also benefitted from EIP presentations and training. Consideration should be given to standardizing and documenting EIP training and to sharing useful training initiatives with other state and local health departments and academic institutions.Entities:
Keywords: Emerging Infections Program; epidemiology; public health; training
Mesh:
Year: 2015 PMID: 26291924 PMCID: PMC4550163 DOI: 10.3201/eid2109.150443
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Examples of surveillance activities and epidemiologic projects involving trainees, Emerging Infections Program sites, United States, 1995–2014
| Surveillance and epidemiologic projects |
|---|
| A. Invasive bacterial diseases |
| a. Invasive pneumococcal disease |
| b. Pneumococcal conjugate vaccine effectiveness |
| c. Pneumococcal carriage |
| d. Invasive group B streptococcal disease |
| e. Invasive group A streptococcal disease |
| f. |
| B. Foodborne diseases |
| a. |
| b. |
| c. |
| d. |
| e. Shiga toxin–producing |
| f. |
| C. Health care–associated infections |
| a. Methicillin-resistant |
| b. |
| D. Influenza |
| a. Influenza surveillance |
| b. Influenza A(H1N1) hospitalizations |
| c. Guillain-Barré syndrome surveillance |
| E. Other diseases or conditions |
| a. Unexplained illness and death surveillance |
| b. Fungal infection surveillance |
| c. Tickborne disease surveillance |
| d. Acute/chronic liver disease surveillance |
| e. Encephalitis etiology |
| f. Human papillomavirus vaccine effectiveness |